Moderate sedation for MRI in young children with autism.

Published

Journal Article

UNLABELLED: Autism is a pervasive neurodevelopmental disorder. Because of the deficits associated with the condition, sedation of children with autism has been considered more challenging than sedation of other children. OBJECTIVE: To test this hypothesis, we compared children with autism against clinical controls to determine differences in requirements for moderate sedation for MRI. MATERIALS AND METHODS: Children ages 18-36 months with autism (group 1, n = 41) and children with no autistic behavior (group 2, n = 42) were sedated with a combination of pentobarbital and fentanyl per sedation service protocol. The sedation nurse was consistent for all patients, and all were sedated to achieve a Modified Ramsay Score of 4. Demographics and doses of sedatives were recorded and compared. RESULTS: There were no sedation failures in either group. Children in group 1 (autism) were significantly older than group 2 (32.02+/-3.6 months vs 28.16+/-6.7 months) and weighed significantly more (14.87+/-2.1 kg vs 13.42+/-2.2 kg). When compared on a per-kilogram basis, however, group 1 had a significantly lower fentanyl requirement than group 2 (1.25+/-0.55 mcg/kg vs 1.57+/-0.81 mcg/kg), but no significant difference was found in pentobarbital dosing between groups 1 and 2, respectively (4.92+/-0.92 mg/kg vs 5.21+/-1.6 mg/kg). CONCLUSION: Autistic children in this age range are not more difficult to sedate and do not require higher doses of sedative agents for noninvasive imaging studies.

Full Text

Duke Authors

Cited Authors

  • Ross, AK; Hazlett, HC; Garrett, NT; Wilkerson, C; Piven, J

Published Date

  • September 2005

Published In

Volume / Issue

  • 35 / 9

Start / End Page

  • 867 - 871

PubMed ID

  • 15902433

Pubmed Central ID

  • 15902433

International Standard Serial Number (ISSN)

  • 0301-0449

Digital Object Identifier (DOI)

  • 10.1007/s00247-005-1499-2

Language

  • eng

Conference Location

  • Germany